These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21334691)

  • 1. Approaches to optimizing vitamin D therapy in prostate cancer.
    Schwartz GG
    J Urol; 2011 Apr; 185(4):1179-80. PubMed ID: 21334691
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D in the prevention and treatment of prostate cancer.
    Konety BR; Johnson CS; Trump DL; Getzenberg RH
    Semin Urol Oncol; 1999 May; 17(2):77-84. PubMed ID: 10332920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.
    Grant WB
    Am J Pathol; 2008 Nov; 173(5):1589-90. PubMed ID: 18948436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and prostate cancer.
    Feldman D; Zhao XY; Krishnan AV
    Endocrinology; 2000 Jan; 141(1):5-9. PubMed ID: 10614617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vitamin D and cancer].
    Yamana K; Saito H; Takenouchi K; Azuma Y; Ishizuka S
    Clin Calcium; 2006 Jul; 16(7):1147-53. PubMed ID: 16816475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroids and prostate cancer.
    Cunha GR; Tuohimaa P; Visakorpi T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):219-20. PubMed ID: 15663985
    [No Abstract]   [Full Text] [Related]  

  • 7. The promiscuous receptor.
    Newsom-Davis TE; Kenny LM; Ngan S; King J; Waxman J
    BJU Int; 2009 Nov; 104(9):1204-7. PubMed ID: 19426197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
    Giovannucci E
    Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis from androgen deprivation therapy in prostate cancer treatment.
    McLeod N; Huynh CC; Rashid P
    Aust Fam Physician; 2006 Apr; 35(4):243-5. PubMed ID: 16642243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.
    Flaig TW; Barqawi A; Miller G; Kane M; Zeng C; Crawford ED; Glodé LM
    Cancer; 2006 Jul; 107(2):266-74. PubMed ID: 16779800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials involving vitamin D analogs in prostate cancer.
    Vijayakumar S; Mehta RR; Boerner PS; Packianathan S; Mehta RG
    Cancer J; 2005; 11(5):362-73. PubMed ID: 16259866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis prophylaxis in men? Adverse effects of total androgen blockade in carcinoma of the prostate].
    Hüfner M
    Internist (Berl); 1999 Aug; 40(8):883. PubMed ID: 10476490
    [No Abstract]   [Full Text] [Related]  

  • 13. New molecular targets in advanced prostate cancer.
    Dawson NA
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):993-1002. PubMed ID: 16831072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of efficacy of the combination of pamidronate and vitamin D on regression of prostate cancer in the Dunning rat model.
    Herring P; Ingels J; Carbone LD; Barrow KD; Osborn D; Dietzen DJ; Pifer L
    J Environ Pathol Toxicol Oncol; 2003; 22(2):vii-viii. PubMed ID: 14533870
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
    Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of insolation on osteoporosis progression in androgen deprived nonmetastatic prostate cancer patients.
    Spanjol J; Maricić A; Valencić M; Oguić R; Krpina K; Protić A; Ivancić A; Bobinac M; Fuckar D; Vojniković B
    Coll Antropol; 2008 Oct; 32 Suppl 2():79-81. PubMed ID: 19138011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).
    Schwartz GG; Hulka BS
    Anticancer Res; 1990; 10(5A):1307-11. PubMed ID: 2241107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of vitamin D in prostatic carcinoma].
    Wilczek H; Vachalovský
    Cas Lek Cesk; 1996 Nov; 135(22):716-8. PubMed ID: 8998822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer survival: is there a dietary connection?
    Holick MF
    Nutr Rev; 2008 Jul; 66(7):425-6; author reply 427. PubMed ID: 18667019
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
    Bonaccorsi L; Marchiani S; Ferruzzi P; Muratori M; Crescioli C; Forti G; Maggi M; Baldi E
    Steroids; 2006 Apr; 71(4):304-9. PubMed ID: 16289173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.